CLX-001(Clinch Biosciences)

N/A

Report date: 2026/01/26 16:40:57
NME

Base Information

Drug NameCLX-001(Clinch Biosciences)
Drug Alias NameCLX-001CLX-001(Clinch Biosciences)
ClassificationOther
Mechanisms of ActionUnconventional myosin-X inhibitors
TargetsUnconventional myosin-X
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClinch Biosciences LLCMetastop
China Registration ClassN/A

Develop Information

Active CompaniesMetastopClinch Biosciences LLC
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A